GB1136039A - Improvements relating to immunosuppressive agents - Google Patents

Improvements relating to immunosuppressive agents

Info

Publication number
GB1136039A
GB1136039A GB45695/66A GB4569566A GB1136039A GB 1136039 A GB1136039 A GB 1136039A GB 45695/66 A GB45695/66 A GB 45695/66A GB 4569566 A GB4569566 A GB 4569566A GB 1136039 A GB1136039 A GB 1136039A
Authority
GB
United Kingdom
Prior art keywords
improvements relating
immunosuppressive agents
ribonuclease
oct
immunosuppressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB45695/66A
Other languages
English (en)
Inventor
James Frederick Mowbray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NAT RES DEV
National Research Development Corp UK
Original Assignee
NAT RES DEV
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NAT RES DEV, National Research Development Corp UK filed Critical NAT RES DEV
Priority to GB45695/66A priority Critical patent/GB1136039A/en
Priority to ES345979A priority patent/ES345979A1/es
Priority to FR1552939D priority patent/FR1552939A/fr
Priority to NL6713800A priority patent/NL6713800A/xx
Priority to FR124050A priority patent/FR7058M/fr
Priority to BE705035D priority patent/BE705035A/xx
Priority to AT926367A priority patent/AT275037B/de
Publication of GB1136039A publication Critical patent/GB1136039A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB45695/66A 1966-10-12 1966-10-12 Improvements relating to immunosuppressive agents Expired GB1136039A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB45695/66A GB1136039A (en) 1966-10-12 1966-10-12 Improvements relating to immunosuppressive agents
ES345979A ES345979A1 (es) 1966-10-12 1967-10-11 Procedimiento para la preparacion de un agente proteinico anti-inmunitario.
FR1552939D FR1552939A (enrdf_load_stackoverflow) 1966-10-12 1967-10-11
NL6713800A NL6713800A (enrdf_load_stackoverflow) 1966-10-12 1967-10-11
FR124050A FR7058M (enrdf_load_stackoverflow) 1966-10-12 1967-10-11
BE705035D BE705035A (enrdf_load_stackoverflow) 1966-10-12 1967-10-12
AT926367A AT275037B (de) 1966-10-12 1967-10-12 Verfahren zur Herstellung von Mitteln zur Hemmung von Immunitätsreaktionen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB45695/66A GB1136039A (en) 1966-10-12 1966-10-12 Improvements relating to immunosuppressive agents

Publications (1)

Publication Number Publication Date
GB1136039A true GB1136039A (en) 1968-12-11

Family

ID=10438194

Family Applications (1)

Application Number Title Priority Date Filing Date
GB45695/66A Expired GB1136039A (en) 1966-10-12 1966-10-12 Improvements relating to immunosuppressive agents

Country Status (6)

Country Link
AT (1) AT275037B (enrdf_load_stackoverflow)
BE (1) BE705035A (enrdf_load_stackoverflow)
ES (1) ES345979A1 (enrdf_load_stackoverflow)
FR (2) FR7058M (enrdf_load_stackoverflow)
GB (1) GB1136039A (enrdf_load_stackoverflow)
NL (1) NL6713800A (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4043869A (en) 1972-07-13 1977-08-23 Koch-Light Laboratories, Ltd. Water insoluble biologically active material
WO2015066550A1 (en) * 2013-10-31 2015-05-07 Resolve Therapeutics, Llc Therapeutic nuclease-albumin fusions and methods

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4043869A (en) 1972-07-13 1977-08-23 Koch-Light Laboratories, Ltd. Water insoluble biologically active material
WO2015066550A1 (en) * 2013-10-31 2015-05-07 Resolve Therapeutics, Llc Therapeutic nuclease-albumin fusions and methods
US10988745B2 (en) 2013-10-31 2021-04-27 Resolve Therapeutics, Llc Therapeutic nuclease-albumin fusions and methods
US12163165B2 (en) 2013-10-31 2024-12-10 Resolve Therapeutics, Llc Nucleic acid molecules encoding nuclease-albumin fusion proteins

Also Published As

Publication number Publication date
FR7058M (enrdf_load_stackoverflow) 1969-06-23
ES345979A1 (es) 1968-12-01
NL6713800A (enrdf_load_stackoverflow) 1968-04-16
AT275037B (de) 1969-10-10
FR1552939A (enrdf_load_stackoverflow) 1969-01-10
BE705035A (enrdf_load_stackoverflow) 1968-04-12

Similar Documents

Publication Publication Date Title
NL7507268A (nl) Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten.
NL7712567A (nl) Werkwijze ter bereiding van trigesubstitueerde 1-fenyl-2,3,4,5-tetrahydro-1h-3-benzazepine verbindingen, alsmede farmaceutische prepara- ten die deze verbindingen als actieve component bevatten.
GB1026456A (en) Improvements in or relating to methods of tedding
GB1261230A (en) Acyl-substituted insulins
NL7706064A (nl) Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten.
GB1136039A (en) Improvements relating to immunosuppressive agents
NL7711414A (nl) Werkwijze ter bereiding van n-gesubstitueerde lactamen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7702180A (nl) Werkwijze ter bereiding van 9-gesubstitueerde- -8-azapurinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
GB1260963A (en) Substituted insulins
NL7409752A (nl) Werkwijze ter bereiding van 1,4-digesubstitueer- de piperidinen alsmede farmaceutische preparaten die deze verbindingen als actieve componenten omvatten.
GB1179787A (en) Stabilised and Potentiated Therapeutic Enzyme Compositions
IE34609L (en) Therapeutic substituted thiazolidinedione
GB1051686A (enrdf_load_stackoverflow)
NL172446C (nl) Werkwijze voor de bereiding van 4-aryl-1-(4.4-diarylbutyl)4-hydroxypiperidinen en werkwijze voor de bereiding van farmaceutische preparaten.
NL7511662A (nl) Werkwijze ter bereiding van 1-gesubstitueerde deri- vaten van 6'n-methyl-3'-4'-dideoxykanamycine b, alsmede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.
NL7513011A (nl) Werkwijze ter bereiding van 1,2,3,4-tetrahydroiso- chinolinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7606457A (nl) Werkwijze ter bereiding van 7(beta)-acyloxycefalospo- rinen en 7(beta)-hydroxy-tussenprodukten alsmede farma- ceutische preparaten die de eerste verbindingen als actieve component omvatten.
GB1339737A (en) Diagnostic agents for primary hepatoma
GB1199951A (en) Modified Dextran and Derivatives Thereof
ES2037603A1 (es) Procedimiento para la obtencion de preparados de enzimas, sin agentes superficie activos, pulverulentos o granulados conteniendo proteasa como enzima activa.
GB1327930A (en) 1,4-benzodiazepine derivatives
NL7709466A (nl) Werkwijze ter bereiding van cefalosporinen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7708177A (nl) Werkwijze ter bereiding van cefemderivaten, als- mede farmaceutische preparaten die deze verbin- ding als actieve component bevatten.
GB1463908A (en) 1-dimethylamino-methyl-6-substituted-4h-s-triazolo-4,3-a- 1,4-benzodiazepine
NL7705446A (nl) Werkwijze ter bereiding van fenethanolaminen met farmaceutische werking alsmede preparaten die deze verbindingen als actieve component bevatten.